Edward Hodgkin, a Managing Partner at Syncona Partners LLP, invests primarily in cell and gene therapy. See sector focus and contact routes.
Edward Hodgkin, a Managing Partner at Syncona Partners LLP, invests primarily in **cell and gene therapy** and **biotech** ventures from **Series A to growth stages**, focusing on transforming groundbreaking scientific discoveries into global leaders[1][12]. His notable portfolio includes **Autolus Therapeutics** (where he was the first CEO), **Resolution Therapeutics** (founding CEO and Chair), **Slingshot Therapeutics** (Executive Chair), and **OMass Therapeutics** (Chair)[2][3][7]. Hodgkin’s distinctive thesis centers on **building and operationalizing early-stage life science companies** from academic labs, often taking executive roles to mature pre-clinical science into clinical assets with key value inflection points[2][5][10].
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in London.
Investors like Edward Hodgkin · Full investor directory · Investor access · Company funding database